Stephens Investment Management Group LLC lifted its holdings in PRA Health Sciences Inc (NASDAQ:PRAH) by 1.5% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 428,661 shares of the medical research company’s stock after purchasing an additional 6,429 shares during the quarter. Stephens Investment Management Group LLC’s holdings in PRA Health Sciences were worth $42,502,000 at the end of the most recent quarter.
Other hedge funds have also bought and sold shares of the company. Motco lifted its position in shares of PRA Health Sciences by 937.0% during the first quarter. Motco now owns 280 shares of the medical research company’s stock worth $31,000 after purchasing an additional 253 shares during the last quarter. Steward Partners Investment Advisory LLC bought a new stake in shares of PRA Health Sciences during the second quarter worth $49,000. Financial Gravity Wealth Inc. bought a new stake in shares of PRA Health Sciences during the first quarter worth $53,000. Manchester Capital Management LLC bought a new stake in shares of PRA Health Sciences during the first quarter worth $57,000. Finally, CENTRAL TRUST Co lifted its position in shares of PRA Health Sciences by 28.2% during the first quarter. CENTRAL TRUST Co now owns 842 shares of the medical research company’s stock worth $93,000 after purchasing an additional 185 shares during the last quarter. 97.98% of the stock is owned by hedge funds and other institutional investors.
Shares of PRAH stock traded up $2.27 on Thursday, hitting $94.75. The stock had a trading volume of 8,979 shares, compared to its average volume of 619,701. The company has a debt-to-equity ratio of 1.11, a quick ratio of 0.99 and a current ratio of 0.99. The business has a 50 day moving average price of $98.26. The company has a market capitalization of $6.11 billion, a P/E ratio of 24.04, a PEG ratio of 1.29 and a beta of 1.12. PRA Health Sciences Inc has a one year low of $82.12 and a one year high of $121.98.
PRA Health Sciences (NASDAQ:PRAH) last released its quarterly earnings data on Wednesday, July 31st. The medical research company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.11. The firm had revenue of $763.31 million during the quarter, compared to the consensus estimate of $764.95 million. PRA Health Sciences had a return on equity of 26.64% and a net margin of 5.39%. The firm’s quarterly revenue was up 5.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.00 earnings per share. On average, research analysts predict that PRA Health Sciences Inc will post 4.63 earnings per share for the current fiscal year.
PRAH has been the subject of several research analyst reports. BidaskClub upgraded PRA Health Sciences from a “hold” rating to a “buy” rating in a research report on Wednesday, July 24th. Mizuho set a $100.00 target price on PRA Health Sciences and gave the stock a “hold” rating in a research report on Friday, May 3rd. Leerink Swann assumed coverage on PRA Health Sciences in a research report on Tuesday, July 2nd. They set a “market perform” rating and a $105.00 target price for the company. Finally, Svb Leerink restated a “market perform” rating on shares of PRA Health Sciences in a report on Tuesday, July 2nd. Eight analysts have rated the stock with a hold rating and two have given a buy rating to the company. PRA Health Sciences presently has an average rating of “Hold” and an average target price of $113.40.
PRA Health Sciences Profile
PRA Health Sciences, Inc, a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services.
Featured Story: How do buyers and sellers choose a strike price?
Want to see what other hedge funds are holding PRAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PRA Health Sciences Inc (NASDAQ:PRAH).
Receive News & Ratings for PRA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PRA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.